Hitoshi Katada

Title: Hitoshi Katada: Innovator in Antibody Research

Introduction

Hitoshi Katada is a prominent inventor based in Singapore, known for his contributions to the field of antibody research. He holds 2 patents that focus on innovative methods and applications of anti-CTLA-4 antibodies. His work has significant implications in the medical and biotechnological sectors.

Latest Patents

Hitoshi Katada's latest patents include the development of anti-CTLA-4 antibodies and methods for their production and use. The disclosures provide detailed information on nucleic acids encoding these antibodies and host cells that contain them. Additionally, the patents describe polypeptides with a variant Fc region that includes amino acid alterations, along with methods for producing and utilizing these polypeptides.

Career Highlights

Throughout his career, Hitoshi Katada has worked with notable organizations such as Chugai Seiyaku Kabushiki Kaisha and Osaka University. His experience in these institutions has contributed to his expertise in antibody research and development.

Collaborations

Hitoshi has collaborated with several professionals in his field, including Kanako Tatsumi and Shun Shimizu. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Hitoshi Katada is a significant figure in the realm of antibody research, with a focus on anti-CTLA-4 antibodies. His patents and career achievements reflect his dedication to advancing medical science and biotechnology.